TGFB1 and breast cancer: The miR-106b-25 cluster targets the inhibitory Smad7 protein, resulting in the overexpression of TGF-βR I, and activates TGF-β signaling to induce EMT and the tumor-promoting effect of Six1 treatment in human breast cancer cells [127].